$PHAS Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in PhaseBio Pharmaceuticals Inc.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in PhaseBio Pharmaceuticals Inc. Get notifications about new insider transactions in PhaseBio Pharmaceuticals Inc for free.

Page:   1 2 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Nov 23 2020PHASPhaseBio Pharmaceu ...Sharp John PChief Financial Off ...GrantA3.001,3053,91541,30540 K to 41.3 K (+3.26 %)
Nov 23 2020PHASPhaseBio Pharmaceu ...Hanson KristopherVP, Head of LegalGrantA3.009992,9979990 to 999
Nov 23 2020PHASPhaseBio Pharmaceu ...York MichaelVP, Corporate Devel ...GrantA3.002,6627,9864,1621.5 K to 4.2 K (+177.47 %)
Nov 23 2020PHASPhaseBio Pharmaceu ...Ballance David JamesVP, Research and Sc ...GrantA3.009192,7578,5197.6 K to 8.5 K (+12.09 %)
Nov 23 2020PHASPhaseBio Pharmaceu ...Arnold Susan ElizabethVP, Preclinical and ...GrantA3.004,83214,49617,98413.2 K to 18 K (+36.74 %)
Nov 23 2020PHASPhaseBio Pharmaceu ...Mow Jonathan PChief Executive Off ...GrantA3.003,64310,929122,886119.2 K to 122.9 K (+3.06 %)
Nov 23 2020PHASPhaseBio Pharmaceu ...Burkhardt GlenVP, Human ResourcesSellS3.453,49712,06503.5 K to 0 (-100.00 %)
Nov 23 2020PHASPhaseBio Pharmaceu ...Burkhardt GlenVP, Human ResourcesGrantA3.003,49710,4913,4970 to 3.5 K
Oct 05 2020PHASPhaseBio Pharmaceu ...Arnold Susan ElizabethVP, Preclinical and ...Option ExerciseM1.155,4236,2360
Oct 05 2020PHASPhaseBio Pharmaceu ...Arnold Susan ElizabethVP, Preclinical and ...Option ExerciseM1.155,4236,2360
Oct 05 2020PHASPhaseBio Pharmaceu ...Arnold Susan ElizabethVP, Preclinical and ...BuyM1.155,4236,23613,1527.7 K to 13.2 K (+70.16 %)
Oct 05 2020PHASPhaseBio Pharmaceu ...Arnold Susan ElizabethVP, Preclinical and ...BuyM1.155,4236,2367,7292.3 K to 7.7 K (+235.17 %)
Aug 24 2020PHASPhaseBio Pharmaceu ...Mow Jonathan PChief Executive Off ...Option ExerciseM1.2410,00012,400148,767
Aug 24 2020PHASPhaseBio Pharmaceu ...Mow Jonathan PChief Executive Off ...BuyM1.2410,00012,400119,243109.2 K to 119.2 K (+9.15 %)
Aug 17 2020PHASPhaseBio Pharmaceu ...Sharp John PChief Financial Off ...Option ExerciseM1.695,0008,450105,582
Aug 17 2020PHASPhaseBio Pharmaceu ...Sharp John PChief Financial Off ...BuyM1.695,0008,45040,00035 K to 40 K (+14.29 %)
Jun 05 2020PHASPhaseBio Pharmaceu ...Thorp ClayDirectorOption ExerciseA4.8616,00077,76016,000
Jun 05 2020PHASPhaseBio Pharmaceu ...Klein Peter JustinDirectorOption ExerciseA4.8616,00077,76016,000
Jun 05 2020PHASPhaseBio Pharmaceu ...van den Broek RichardDirectorOption ExerciseA4.8616,00077,76016,000
Jun 05 2020PHASPhaseBio Pharmaceu ...Hutson Nancy JDirectorOption ExerciseA4.8616,00077,76016,000
Jun 05 2020PHASPhaseBio Pharmaceu ...HARRIGAN EDMUNDDirectorOption ExerciseA4.8616,00077,76016,000
Jun 05 2020PHASPhaseBio Pharmaceu ...Loewy Caroline MDirectorOption ExerciseA0.0016,000016,000
Jun 05 2020PHASPhaseBio Pharmaceu ...Sapir AlexDirectorOption ExerciseA4.864,90923,8584,909
Feb 14 2020PHASPhaseBio Pharmaceu ...Mow Jonathan PChief Executive Off ...Option ExerciseA5.19290,0001,505,100290,000
Feb 14 2020PHASPhaseBio Pharmaceu ...Ballance David JamesVP, Research and Sc ...Option ExerciseA5.1955,000285,45055,000
Feb 14 2020PHASPhaseBio Pharmaceu ...Arnold Susan ElizabethVP, Preclinical and ...Option ExerciseA5.1955,000285,45055,000
Feb 14 2020PHASPhaseBio Pharmaceu ...Lee John SangChief Medical Offic ...Option ExerciseA5.19100,000519,000100,000
Feb 14 2020PHASPhaseBio Pharmaceu ...Sapir AlexDirectorOption ExerciseA5.1932,000166,08032,000
Feb 14 2020PHASPhaseBio Pharmaceu ...Hanson KristopherVP, Head of LegalOption ExerciseA5.1955,000285,45055,000
Feb 14 2020PHASPhaseBio Pharmaceu ...Sharp John PChief Financial Off ...Option ExerciseA5.19100,000519,000100,000
Feb 14 2020PHASPhaseBio Pharmaceu ...York MichaelVP, Corporate Devel ...Option ExerciseA5.1955,000285,45055,000
Feb 14 2020PHASPhaseBio Pharmaceu ...Burkhardt GlenVP, Human ResourcesOption ExerciseA5.1920,000103,80020,000
Feb 14 2020PHASPhaseBio Pharmaceu ...Burkhardt GlenVP, Human ResourcesOption ExerciseA5.1955,000285,45055,000
Oct 07 2019PHASPhaseBio Pharmaceu ...Hanson KristopherVice President, Hea ...Option ExerciseA4.1766,000275,22066,000
Oct 07 2019PHASPhaseBio Pharmaceu ...Hanson KristopherVice President, Hea ...Option ExerciseA4.1766,000275,22066,000
Sep 10 2019PHASPhaseBio Pharmaceu ...Mow Jonathan PChief Executive Off ...Option ExerciseM1.2419,00023,560158,767
Sep 10 2019PHASPhaseBio Pharmaceu ...Mow Jonathan PChief Executive Off ...BuyM1.2419,00023,560109,24390.2 K to 109.2 K (+21.05 %)
Aug 22 2019PHASPhaseBio Pharmaceu ...Sharp John PCFO and SecretaryOption ExerciseM1.445,0007,2004,038
Aug 22 2019PHASPhaseBio Pharmaceu ...Sharp John PCFO and SecretaryOption ExerciseM1.6910,00016,900110,582
Aug 22 2019PHASPhaseBio Pharmaceu ...Sharp John PCFO and SecretaryBuyM1.445,0007,20035,00030 K to 35 K (+16.67 %)
Aug 22 2019PHASPhaseBio Pharmaceu ...Sharp John PCFO and SecretaryBuyM1.6910,00016,90030,00020 K to 30 K (+50.00 %)
Jul 03 2019PHASPhaseBio Pharmaceu ...Thorp ClayDirectorSellS14.004596,426415,959416.4 K to 416 K (-0.11 %)
Jul 03 2019PHASPhaseBio Pharmaceu ...Thorp ClayDirectorSellS14.002553,57052,39752.7 K to 52.4 K (-0.48 %)
Jul 03 2019PHASPhaseBio Pharmaceu ...Thorp ClayDirectorSellS14.001802,520162,890163.1 K to 162.9 K (-0.11 %)
Jul 03 2019PHASPhaseBio Pharmaceu ...Thorp ClayDirectorSellS14.002,01428,1961,818,6381.8 M to 1.8 M (-0.11 %)
Jun 20 2019PHASPhaseBio Pharmaceu ...Thorp ClayDirectorSellS14.0063882416,418416.5 K to 416.4 K (-0.02 %)
Jun 20 2019PHASPhaseBio Pharmaceu ...Thorp ClayDirectorSellS14.003549052,65552.7 K to 52.7 K (-0.07 %)
Jun 20 2019PHASPhaseBio Pharmaceu ...Thorp ClayDirectorSellS14.0025350163,074163.1 K to 163.1 K (-0.02 %)
Jun 20 2019PHASPhaseBio Pharmaceu ...Thorp ClayDirectorSellS14.002773,8781,820,6561.8 M to 1.8 M (-0.02 %)
May 24 2019PHASPhaseBio Pharmaceu ...Sharp John PCFO and SecretaryOption ExerciseM1.6915,00025,350120,582
May 24 2019PHASPhaseBio Pharmaceu ...Sharp John PCFO and SecretaryBuyM1.6915,00025,35020,0005 K to 20 K (+300.00 %)
May 21 2019PHASPhaseBio Pharmaceu ...Mow Jonathan PChief Executive Off ...Option ExerciseM1.2419,13123,7220
May 21 2019PHASPhaseBio Pharmaceu ...Mow Jonathan PChief Executive Off ...Option ExerciseM2.2719,91345,2030
May 21 2019PHASPhaseBio Pharmaceu ...Mow Jonathan PChief Executive Off ...BuyM1.2419,13123,72290,24371.1 K to 90.2 K (+26.90 %)
May 21 2019PHASPhaseBio Pharmaceu ...Mow Jonathan PChief Executive Off ...BuyM2.2719,91345,20371,11251.2 K to 71.1 K (+38.89 %)
May 13 2019PHASPhaseBio Pharmaceu ...Mukhopadhyay BibhashDirectorOption ExerciseA13.2311,000145,53011,000
May 13 2019PHASPhaseBio Pharmaceu ...Mukhopadhyay BibhashDirectorOption ExerciseA13.2311,000145,53011,000
May 13 2019PHASPhaseBio Pharmaceu ...Klein Peter JustinDirectorOption ExerciseA13.2311,000145,53011,000
May 13 2019PHASPhaseBio Pharmaceu ...van den Broek RichardDirectorOption ExerciseA13.232,75036,3832,750
May 13 2019PHASPhaseBio Pharmaceu ...HARRIGAN EDMUNDDirectorOption ExerciseA13.234,58360,6334,583
May 13 2019PHASPhaseBio Pharmaceu ...Loewy Caroline MDirectorOption ExerciseA13.239,167121,2799,167
May 13 2019PHASPhaseBio Pharmaceu ...Hutson Nancy JDirectorOption ExerciseA13.2311,000145,53011,000
May 13 2019PHASPhaseBio Pharmaceu ...Thorp ClayDirectorOption ExerciseA13.2311,000145,53011,000
Mar 01 2019PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseA3.1536,000113,40036,000
Mar 01 2019PHASPhaseBio Pharmaceu ...York MichaelVP, Corporate Devel ...Option ExerciseA3.1545,000141,75045,000
Mar 01 2019PHASPhaseBio Pharmaceu ...van den Broek RichardDirectorOption ExerciseA3.1523,00072,45023,000
Mar 01 2019PHASPhaseBio Pharmaceu ...van den Broek RichardDirectorOption ExerciseA3.1522,00069,30022,000
Mar 01 2019PHASPhaseBio Pharmaceu ...Thorp ClayDirectorOption ExerciseA3.1536,000113,40036,000
Mar 01 2019PHASPhaseBio Pharmaceu ...Sharp John PCFO and SecretaryOption ExerciseA3.15100,000315,000100,000
Mar 01 2019PHASPhaseBio Pharmaceu ...Loewy Caroline MDirectorOption ExerciseA3.158,90028,0358,900
Mar 01 2019PHASPhaseBio Pharmaceu ...Klein Peter JustinDirectorOption ExerciseA3.1536,000113,40036,000
Mar 01 2019PHASPhaseBio Pharmaceu ...Klein Peter JustinDirectorOption ExerciseA3.1536,000113,40036,000
Mar 01 2019PHASPhaseBio Pharmaceu ...Hutson Nancy JDirectorOption ExerciseA3.158,90028,0358,900
Mar 01 2019PHASPhaseBio Pharmaceu ...Hutson Nancy JDirectorOption ExerciseA3.158,90028,0358,900
Mar 01 2019PHASPhaseBio Pharmaceu ...Ballance David JamesVP, Research and Sc ...Option ExerciseA3.1545,000141,75045,000
Mar 01 2019PHASPhaseBio Pharmaceu ...Ballance David JamesVP, Research and Sc ...Option ExerciseA3.1545,000141,75045,000
Mar 01 2019PHASPhaseBio Pharmaceu ...Arnold Susan ElizabethVP, Preclinical and ...Option ExerciseA3.1545,000141,75045,000
Mar 01 2019PHASPhaseBio Pharmaceu ...Arnold Susan ElizabethVP, Preclinical and ...Option ExerciseA3.1545,000141,75045,000
Mar 01 2019PHASPhaseBio Pharmaceu ...Mow Jonathan PChief Executive Off ...Option ExerciseA3.15263,000828,450263,000
Mar 01 2019PHASPhaseBio Pharmaceu ...Mow Jonathan PChief Executive Off ...Option ExerciseA3.15263,000828,450263,000
Mar 01 2019PHASPhaseBio Pharmaceu ...Mukhopadhyay BibhashDirectorOption ExerciseA3.1536,000113,40036,000
Mar 01 2019PHASPhaseBio Pharmaceu ...Mukhopadhyay BibhashDirectorOption ExerciseA3.1536,000113,40036,000
Dec 17 2018PHASPhaseBio Pharmaceu ...HARRIGAN EDMUNDDirectorOption ExerciseA3.6568,966251,72668,966
Dec 17 2018PHASPhaseBio Pharmaceu ...Ballance David JamesVP, Research and Sc ...BuyP3.941,0003,9407,6006.6 K to 7.6 K (+15.15 %)
Dec 17 2018PHASPhaseBio Pharmaceu ...Hutson Nancy JDirectorBuyP4.461,0004,4601,0000 to 1,000
Dec 17 2018PHASPhaseBio Pharmaceu ...Mow Jonathan PChief Executive Off ...BuyP3.691,0003,69051,19950.2 K to 51.2 K (+1.99 %)
Dec 11 2018PHASPhaseBio Pharmaceu ...York MichaelVP, Corporate Devel ...BuyP3.881,5005,8201,5000 to 1.5 K
Dec 11 2018PHASPhaseBio Pharmaceu ...Sharp John PCFO and SecretaryBuyP3.845,00019,2005,0000 to 5 K
Dec 11 2018PHASPhaseBio Pharmaceu ...Mow Jonathan PChief Executive Off ...BuyP3.858003,08051,69950.9 K to 51.7 K (+1.57 %)
Dec 11 2018PHASPhaseBio Pharmaceu ...Mow Jonathan PChief Executive Off ...BuyP3.882,2008,53650,89948.7 K to 50.9 K (+4.52 %)
Dec 06 2018PHASPhaseBio Pharmaceu ...Thorp ClayDirectorBuyP3.134,00012,52015,79911.8 K to 15.8 K (+33.90 %)
Oct 24 2018PHASPhaseBio Pharmaceu ...Klein Peter JustinDirectorOption ExerciseC0.002,30300
Oct 24 2018PHASPhaseBio Pharmaceu ...Klein Peter JustinDirectorOption ExerciseS0.00302,303
Oct 24 2018PHASPhaseBio Pharmaceu ...Klein Peter JustinDirectorOption ExerciseX0.0010302,306
Oct 24 2018PHASPhaseBio Pharmaceu ...Klein Peter JustinDirectorOption ExerciseX0.12103120
Oct 24 2018PHASPhaseBio Pharmaceu ...Klein Peter JustinDirectorBuyC0.002,30302,3030 to 2.3 K
Oct 24 2018PHASPhaseBio Pharmaceu ...NEW ENTERPRISE ASSOCIATES 13 L ...10% OwnerOption ExerciseC0.001,124,30100
Oct 24 2018PHASPhaseBio Pharmaceu ...NEW ENTERPRISE ASSOCIATES 13 L ...10% OwnerOption ExerciseC0.00437,70600
Oct 24 2018PHASPhaseBio Pharmaceu ...NEW ENTERPRISE ASSOCIATES 13 L ...10% OwnerOption ExerciseS0.004,3490437,706
Oct 24 2018PHASPhaseBio Pharmaceu ...NEW ENTERPRISE ASSOCIATES 13 L ...10% OwnerOption ExerciseX0.00181,1900442,055
Oct 24 2018PHASPhaseBio Pharmaceu ...NEW ENTERPRISE ASSOCIATES 13 L ...10% OwnerOption ExerciseX0.12181,19021,7430
Oct 24 2018PHASPhaseBio Pharmaceu ...NEW ENTERPRISE ASSOCIATES 13 L ...10% OwnerOption ExerciseC0.003,279,62700
Oct 24 2018PHASPhaseBio Pharmaceu ...NEW ENTERPRISE ASSOCIATES 13 L ...10% OwnerOption ExerciseS0.001,17703,279,627
Oct 24 2018PHASPhaseBio Pharmaceu ...NEW ENTERPRISE ASSOCIATES 13 L ...10% OwnerOption ExerciseX0.0049,03003,280,804
Oct 24 2018PHASPhaseBio Pharmaceu ...NEW ENTERPRISE ASSOCIATES 13 L ...10% OwnerOption ExerciseX0.1249,0305,8840
Oct 24 2018PHASPhaseBio Pharmaceu ...NEW ENTERPRISE ASSOCIATES 13 L ...10% OwnerBuyP5.001,800,0009,000,0006,641,6344.8 M to 6.6 M (+37.18 %)
Oct 24 2018PHASPhaseBio Pharmaceu ...NEW ENTERPRISE ASSOCIATES 13 L ...10% OwnerBuyC0.004,841,63404,841,6340 to 4.8 M
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseC0.0030,33400
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseC0.006,41300
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseC0.0063,68800
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseC0.0022,45200
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseC0.004,74600
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseC0.0047,14000
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseC0.00165,39500
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseC0.0034,96800
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseC0.00347,25000
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseC0.0056,87400
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseC0.0012,02500
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseC0.00119,40800
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseS0.00113022,452
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseM0.004,690022,565
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseM0.124,6905630
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseS0.002404,746
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseM0.0099104,770
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseM0.129911190
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseS0.00237047,140
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseM0.009,847047,377
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseM0.129,8471,1820
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseS0.00810165,395
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseM0.003,3590165,476
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseM0.123,3594030
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseS0.0018034,968
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseM0.00710034,986
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseM0.12710850
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseS0.001700347,250
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseM0.007,0530347,420
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorOption ExerciseM0.127,0538460
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorBuyP5.006,04130,205281,096275.1 K to 281.1 K (+2.20 %)
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorBuyC0.00275,0550275,0550 to 275.1 K
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorBuyP5.001,2776,38559,42958.2 K to 59.4 K (+2.20 %)
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorBuyC0.0058,152058,1520 to 58.2 K
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorBuyP5.0012,68263,410590,168577.5 K to 590.2 K (+2.20 %)
Oct 24 2018PHASPhaseBio Pharmaceu ...TUFTS LINDADirectorBuyC0.00577,4860577,4860 to 577.5 K
Oct 24 2018PHASPhaseBio Pharmaceu ...Thorp ClayDirectorOption ExerciseC0.00226,06100
Oct 24 2018PHASPhaseBio Pharmaceu ...Thorp ClayDirectorOption ExerciseC0.0024,70900
Oct 24 2018PHASPhaseBio Pharmaceu ...Thorp ClayDirectorOption ExerciseC0.00272,10700
Oct 24 2018PHASPhaseBio Pharmaceu ...Thorp ClayDirectorOption ExerciseC0.0040,42000
Oct 24 2018PHASPhaseBio Pharmaceu ...Thorp ClayDirectorOption ExerciseC0.0013,55800
Oct 24 2018PHASPhaseBio Pharmaceu ...Thorp ClayDirectorOption ExerciseC0.00149,32000
Oct 24 2018PHASPhaseBio Pharmaceu ...Thorp ClayDirectorOption ExerciseC0.0094,87400

Page:   1 2 next >